Our Stories

The Medicines Amendment Bill 2025

Rebecca Robson 06/06/2025 Rebecca Robson 06/06/2025

The Medicines Amendment Bill 2025

Read More

BioOra scaling up manufacturing to support the Malaghan Institute’s phase 2 trial to register CD19-specific CAR T

Rebecca Robson 28/01/2025 Rebecca Robson 28/01/2025

BioOra scaling up manufacturing to support the Malaghan Institute’s phase 2 trial to register CD19-specific CAR T

Read More

BioOra Appoints John Robson as Managing Director</span>

Guest User 20/06/2024 Guest User 20/06/2024

BioOra Appoints John Robson as Managing Director

BioOra has appointed John Robson as Managing Director!

Read More

Significant Milestone Reached in New Zealand’s First CAR T-Cell Therapy Trial

Rebecca Robson 25/03/2024 Rebecca Robson 25/03/2024

Significant Milestone Reached in New Zealand’s First CAR T-Cell Therapy Trial

Read More

Clinical Trial Results Support BioOra’s Automated CAR T-Cell Manufacturing for Next Phase

Rebecca Robson 12/12/2023 Rebecca Robson 12/12/2023

Clinical Trial Results Support BioOra’s Automated CAR T-Cell Manufacturing for Next Phase

Read More

BioOra Welcomes CAR T-Cell Pioneer Professor Carl June to Board of Directors

Rebecca Robson 31/10/2023 Rebecca Robson 31/10/2023

BioOra Welcomes CAR T-Cell Pioneer Professor Carl June to Board of Directors

Read More